Details of the Drug

General Information of Drug (ID: DMS0I49)

Drug Name
OTL38
Indication
Disease Entry ICD 11 Status REF
Ovarian cancer 2C73 Phase 2 [1]
Cross-matching ID
PubChem CID
135565623
TTD ID
D0I9IL

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)